샘플 요청 목록

 카트 문의
시장보고서
상품코드
1936876

비인두 스왑 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Nasopharyngeal Swab Market Size, Share, Trends & Growth Analysis Report 2026-2034
발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 103 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

비인두 스왑 시장 규모는 2025년 2억 8,028만 달러에서 2034년에는 3억 4,698만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 2.4%로 성장할 것으로 전망됩니다.

전 세계 보건 위기에 따라 정확한 진단 도구에 대한 수요가 증가함에 따라 비인두 스왑 시장은 혁신적인 성장의 기로에 서 있습니다. COVID-19를 포함한 호흡기질환이 공중보건의 심각한 문제로 대두되고 있는 가운데, 신뢰할 수 있는 검체 채취 방법의 필요성이 그 어느 때보다 중요해지고 있습니다. 비인두 스왑은 바이러스 및 세균성 병원체 검출에 필수적이며, 임상 현장과 검사실 모두에서 없어서는 안 될 필수품입니다. 의료 서비스 제공자들이 감염병을 효과적으로 관리하기 위해 신속하고 정확한 진단 솔루션을 찾고 있는 가운데, 분자진단 기술의 지속적인 발전과 현장 진료 검사의 증가는 시장을 더욱 촉진할 것으로 예상됩니다.

또한, 면봉의 디자인과 소재의 기술적 진보도 검체 채취 과정의 효율성과 편안함을 향상시킬 것으로 예상됩니다. 유연하고 부드러운 면봉과 개선된 채취 기술과 같은 혁신은 환자의 협조도를 높일 뿐만 아니라 오염 위험과 위음성 발생률을 낮출 수 있습니다. 제조업체들이 차세대 면봉 개발을 위한 연구개발에 투자함에 따라, 특정 진단 니즈에 맞는 제품 라인업이 다양화될 것으로 예상됩니다. 또한, 원격의료 및 모바일 건강 애플리케이션과 같은 디지털 건강 기술의 통합으로 원격 검사 및 모니터링이 촉진되어 비인두 스왑의 적용 범위가 기존 의료 현장을 넘어 확장될 것입니다.

또한, 예방 의료와 질병 조기 발견에 대한 관심이 높아짐에 따라 비인두 스왑 시장은 수혜를 입을 것입니다. 전 세계 의료 시스템이 감염병을 적극적으로 관리하는 방향으로 전환함에 따라 효율적인 검체 채취 방법에 대한 수요가 증가하고 있습니다. 감시체계 강화와 감염병 발생 시 대응을 위한 공중보건 대책에 따라 학교, 직장, 지역 의료센터 등 다양한 환경에서 비인두 스왑 사용이 더욱 활성화될 것입니다. 시장이 발전함에 따라 진단 기업, 의료 제공자 및 공중 보건 기관 간의 전략적 제휴는 비인두 스왑의 광범위한 보급과 활용을 보장하는 데 매우 중요하며, 궁극적으로 전 세계 건강 상태 개선에 기여하게 될 것입니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 비인두 스왑 시장 : 유형별

제5장 세계의 비인두 스왑 시장 : 지역별

제6장 경쟁 구도

제7장 기업 개요

KSM 26.03.11

The Nasopharyngeal Swab Market size is expected to reach USD 346.98 Million in 2034 from USD 280.28 Million (2025) growing at a CAGR of 2.4% during 2026-2034.

The nasopharyngeal swab market is on the brink of transformative growth, driven by the increasing demand for accurate diagnostic tools in the wake of global health crises. As respiratory diseases, including COVID-19, continue to pose significant public health challenges, the need for reliable sampling methods has never been more critical. Nasopharyngeal swabs are essential for the detection of viral and bacterial pathogens, making them indispensable in both clinical and laboratory settings. The ongoing evolution of molecular diagnostics and the rise of point-of-care testing are expected to further propel the market, as healthcare providers seek rapid and precise diagnostic solutions to manage infectious diseases effectively.

Technological advancements in swab design and materials are also set to enhance the efficiency and comfort of the sampling process. Innovations such as flexible, ultra-soft swabs and improved collection techniques will not only increase patient compliance but also reduce the risk of contamination and false negatives. As manufacturers invest in research and development to create next-generation swabs, the market will likely witness a diversification of product offerings tailored to specific diagnostic needs. Additionally, the integration of digital health technologies, such as telemedicine and mobile health applications, will facilitate remote testing and monitoring, expanding the reach of nasopharyngeal swabs beyond traditional healthcare settings.

Furthermore, the nasopharyngeal swab market will benefit from the growing emphasis on preventive healthcare and early disease detection. As healthcare systems worldwide shift towards proactive management of infectious diseases, the demand for efficient sampling methods will increase. Public health initiatives aimed at enhancing surveillance and outbreak response will further drive the adoption of nasopharyngeal swabs in various settings, including schools, workplaces, and community health centers. As the market evolves, strategic partnerships between diagnostic companies, healthcare providers, and public health organizations will be crucial in ensuring the widespread availability and utilization of nasopharyngeal swabs, ultimately contributing to improved health outcomes on a global scale.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Foam Tipped Swabs
  • Non-woven Swabs
  • Others
  • Application
  • Influenza
  • COVID-19
  • Respiratory Syncytial Virus
  • Bordetella Pertussis Infection
  • MRSA (Methicillin-resistant Staphylococcus aureus)
  • Others
  • End-user
  • Hospitals
  • Clinics
  • Academia & Research Institutes
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific, Inc, CR Bard, Inc Becton, Dickinson and Company, Medical Wire Equipment MWE, Titan Biotech Ltd, Copan Diagnostics, Inc, Miraclean Technology Co, Ltd, Puritan Medical Products, Yocon Biology, Trinity Biotech, VircellsL, Quidel Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NASOPHARYNGEAL SWAB MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Foam Tipped Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Non-woven Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Respiratory Syncytial Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Bordetella Pertussis Infection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. MRSA (Methicillin-resistant Staphylococcus aureus) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.12. End-user Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.13. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.14. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.15. Academia & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.16. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NASOPHARYNGEAL SWAB MARKET: BY REGION 2022-2034(USD MN)

  • 5.1. Regional Outlook
  • 5.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.2.1 By Type
    • 5.2.2 United States
    • 5.2.3 Canada
    • 5.2.4 Mexico
  • 5.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.3.1 By Type
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Germany
    • 5.3.5 Italy
    • 5.3.6 Russia
    • 5.3.7 Rest Of Europe
  • 5.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.4.1 By Type
    • 5.4.2 India
    • 5.4.3 Japan
    • 5.4.4 South Korea
    • 5.4.5 Australia
    • 5.4.6 South East Asia
    • 5.4.7 Rest Of Asia Pacific
  • 5.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.5.1 By Type
    • 5.5.2 Brazil
    • 5.5.3 Argentina
    • 5.5.4 Peru
    • 5.5.5 Chile
    • 5.5.6 South East Asia
    • 5.5.7 Rest of Latin America
  • 5.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.6.1 By Type
    • 5.6.2 Saudi Arabia
    • 5.6.3 UAE
    • 5.6.4 Israel
    • 5.6.5 South Africa
    • 5.6.6 Rest of the Middle East And Africa

Chapter 6. COMPETITIVE LANDSCAPE

  • 6.1. Recent Developments
  • 6.2. Company Categorization
  • 6.3. Supply Chain & Channel Partners (based on availability)
  • 6.4. Market Share & Positioning Analysis (based on availability)
  • 6.5. Vendor Landscape (based on availability)
  • 6.6. Strategy Mapping

Chapter 7. COMPANY PROFILES OF GLOBAL NASOPHARYNGEAL SWAB INDUSTRY

  • 7.1. Top Companies Market Share Analysis
  • 7.2. Company Profiles
    • 7.2.1 Thermo Fisher ScientificInc
    • 7.2.2 C.R. Bard, Inc. (Becton, Dickinson And Company)
    • 7.2.3 Medical Wire & Equipment (MWE)
    • 7.2.4 Titan Biotech Ltd
    • 7.2.5 Copan DiagnosticsInc
    • 7.2.6 Miraclean Technology Co.Ltd
    • 7.2.7 Puritan Medical Products
    • 7.2.8 Yocon Biology
    • 7.2.9 Trinity Biotech
    • 7.2.10 Vircells.L
    • 7.2.11 Quidel Corporation
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제